These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1795 related articles for article (PubMed ID: 8464756)
1. [The effect of ethylenediaminetetramethylenephosphonate on the biodistribution of tumor-seeking radionuclides]. Schomäcker K; Franke WG; Mäding P; Shukla SK; Weiss S; Limouris GS; Jantsch K Nuklearmedizin; 1993 Feb; 32(1):23-6. PubMed ID: 8464756 [TBL] [Abstract][Full Text] [Related]
2. [The effect of bone-seeking metal salts on the biodistribution of tumor-seeking heavy metal complexes]. Schomäcker K; Franke WG; Weiss S; Lindner L; Jantsch K; Shukla SK; Limouris GS Nuklearmedizin; 1993 Feb; 32(1):27-33. PubMed ID: 8464757 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats. Beyer GJ; Bergmann R; Kampf G; Mäding P; Rösch F Int J Rad Appl Instrum B; 1992 Feb; 19(2):201-3. PubMed ID: 1601673 [TBL] [Abstract][Full Text] [Related]
11. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. Goeckeler WF; Edwards B; Volkert WA; Holmes RA; Simon J; Wilson D J Nucl Med; 1987 Apr; 28(4):495-504. PubMed ID: 3572535 [TBL] [Abstract][Full Text] [Related]
12. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life]. Jiang CY; Zhu BL; Zhang YJ Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052 [TBL] [Abstract][Full Text] [Related]
14. Samarium-153-EDTMP biodistribution and dosimetry estimation. Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of carrier added and no carrier added 90Y-EDTMP as bone seeking therapeutic radiopharmaceutical. Khalid M; Bokhari TH; Ahmad M; Bhatti HN; Iqbal M; Ghaffar A; Qadir MI Pak J Pharm Sci; 2014 Jul; 27(4):813-8. PubMed ID: 25015445 [TBL] [Abstract][Full Text] [Related]
16. [Influence on extratumoral organ activities of tumor-affinity samarium-153 preparations]. Schomäcker K; Hebrank H; Scheidhauer K; Scharl A; Saccavini JC; Shukla SK; Franke WG; Schicha H Nuklearmedizin; 1997 Mar; 36(2):47-51. PubMed ID: 9148272 [TBL] [Abstract][Full Text] [Related]
17. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. The ISOLDE Collaboration. Beyer GJ; Offord R; Künzi G; Aleksandrova Y; Ravn U; Jahn S; Barker J; Tengblad O; Lindroos M Nucl Med Biol; 1997 Jul; 24(5):367-72. PubMed ID: 9290069 [TBL] [Abstract][Full Text] [Related]
18. [The effect of Ca-diethylenetriamine pentaacetate on the bio-behavior of tumor-affine metal complexes]. Schomäcker K; Franke WG; Jantsch K; Shukla SK; Limouris GS Nuklearmedizin; 1992 Dec; 31(6):242-8. PubMed ID: 1491964 [TBL] [Abstract][Full Text] [Related]
19. Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias. Keeling AA; Vaughan AT; Beaney RP Br J Cancer; 1989 Jul; 60(1):74-8. PubMed ID: 2803919 [TBL] [Abstract][Full Text] [Related]
20. Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats. Láznícek M; Láznícková A; Budský F; Prokop J; Kopicka K Appl Radiat Isot; 1994 Sep; 45(9):949-53. PubMed ID: 7951182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]